Treos Bio
Venture Round in 2017
Treos Bio, Inc. is a clinical-stage biotechnology company focused on developing precision cancer immunotherapies that are tailored to individual patients' genetic profiles. Founded in 2013 and headquartered in San Francisco, California, Treos Bio employs advanced computational data science and proprietary biomarkers to create targeted immunotherapies. Its product offerings include the PEPI test, which analyzes genetic data from saliva or blood samples to predict a person’s immune response to specific antigens. The company also produces PolyPEPI immunotherapy vaccines designed for various cancers, including melanoma, lung, breast, colorectal, ovarian, glioma, and leukemia. Additionally, Treos Bio offers the PolyPEPI CDx companion diagnostic test to determine the effectiveness of treatments for individual patients, as well as a Melanoma Screening Test that identifies individuals at high risk for melanoma based on genetic information.
Hoyo Hoyo Agribusiness
Venture Round in 2016
Hoyo Hoyo Agribusiness is a oilseed producers in the country, Hoyo Hoyo restores and develops a large scale agricultural concession.
Check-Cap
Debt Financing in 2014
Check-Cap Ltd. is a clinical-stage medical diagnostics company based in Isfiya, Israel, specializing in the development of innovative solutions for colorectal cancer screening. The company's flagship product, the C-Scan system, is a capsule-based technology that utilizes low-dose X-rays to detect colonic polyps and colorectal cancers without the need for bowel preparation or invasive procedures. The C-Scan system consists of three components: the C-Scan Cap, an ingestible capsule that collects and transmits imaging data; the C-Scan Track, a biocompatible device worn by the patient to track the capsule's movement and record data; and C-Scan View, software designed to process and visualize the captured clinical data. This preparation-free approach is intended to provide accuracy comparable to traditional colonoscopy, with the capsule passing naturally through the gastrointestinal tract. Check-Cap aims to bring its technology to markets in the United States, Europe, Israel, and Japan.
Malawi Mangoes
Acquisition in 2013
Malawi Mangoes is a fruit producer based in Malawi that specializes in the cultivation and processing of mango and banana purées. The company is committed to developing sustainable relationships with smallholder farmers, aiming to unify a fragmented agricultural market. By enhancing its agricultural operations and establishing smallholder sourcing schemes, Malawi Mangoes seeks to capitalize on the increasing global demand for tropical fruit purées. Additionally, the company has invested in pulp processing and distribution capabilities to ensure efficient delivery of its products to various markets.
Marex Spectron
Private Equity Round in 2011
Marex Spectron is a global commodity broker with a focus on Metals, Agricultural, and Energy products. They provide a wide range of services to a diverse client base, backed by proprietary technology and analytics. Marex Spectron stands out in the industry for their comprehensive coverage across multiple commodity categories, including Metals, Energy, and Agricultural products, setting them apart from competitors who may specialize in only one area. With platform scalability and top rankings in various sectors, Marex Spectron is a leading player in the commodity brokerage market.
Central European Petroleum
Private Equity Round in 2010
Central European Petroleum is a petroleum exploration and production company focused on the European Union.
ETX Capital
Private Equity Round in 2009
ETX Capital is a prominent player in the CFD and spread betting market, providing a wide array of services to retail, high net worth, and institutional clients via its robust online trading platform. Specializing in multi asset and multi market derivative trading through CFDs and spread betting products, ETX Capital caters to a diverse range of investors. The company has earned recognition for its excellence in the industry, with accolades such as "Best Futures & Options Broker" and "Value for Money" in 2011.